Intellia Therapeutics Inc
NTLA
$12.14-0.98%
End of day · as of Sep 20, 2026, 12:15 PM ET
Mkt cap
$1.19B
EV/Sales
15.4
P/E ratio
N/A
FY2025 Revenue
$67.67M
EPS (TTM)
$-3.34
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-609.85%
Beta
2.13
Div yield
N/A
Sector
Healthcare
Intellia Therapeutics Inc (NTLA) is a biotechnology company listed on US.
Latest reported NTLA revenue for 2025-12-31 was $67.7M. Net income was -$412.7M. Revenue was up 16.9% from 2024-12-31 to 2025-12-31. NTLA currently screens at market cap $1.19B.
Use this NTLA research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full NTLA income, balance, and cash tables.
Intellia Therapeutics Inc (NTLA) is a biotechnology company in the Healthcare sector.
Latest cached Intellia Therapeutics Inc (NTLA) revenue for Dec 31, 2025 was $67.7M. Net income was -$412.7M. Statements: https://lician.com/financials/ntla
Intellia Therapeutics Inc (NTLA) market capitalization is $1.19B on the latest cached snapshot.
Intellia Therapeutics Inc (NTLA) cached previous close $12.26; day range $11.87 – $12.47; volume 8,594,379. Session quote: https://lician.com/quote/ntla
Intellia Therapeutics Inc (NTLA) latest cached earnings event is "NTLA earnings" on Aug 6, 2026. Earnings calendar: https://lician.com/earnings
The latest cached NTLA filing is 8-K · Sep 8, 2026. Filings: https://lician.com/sec/ntla